HeartBeam Inc (BEAT) (Q3 2026) Earnings Call Highlights: FDA Breakthrough Status, ALIGN ACS ...
HeartBeam Inc (BEAT) advances its 510(k) heart attack detection pathway with strong ALIGN ACS results and extended runway into 2027, while Nasdaq compliance and pivotal study timing remain key risks. Related Stocks: BEAT ,